Trial intelligence / Profile preview

Tranexamic Acid in Hip Fracture Surgery

NCT00327106Phase 3Completed

Sponsor
CHU Saint-Etienne
Start
Apr 2005
Primary completion
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in hip fracture, sponsored by CHU Saint-Etienne. Started Apr 2005; status: completed.

02

Drugs

tranexamic acid
03

Conditions

hip fracture

Beyond the preview

Go deeper on NCT00327106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00327106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call